BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Marcus Evans, Life Science and Pharma Conferences: Interview With Michael Shires, Vice President for Project and Portfolio Management at Baxter BioScience Corporation (BAX)


2/7/2013 2:41:47 PM

Marcus Evans 6th Annual Pharma Resource Planning and Portfolio Management

February 07, 2013 -- Investments into the biotechnology space reached record highs in 2012. Mike Shires, Vice President for Project and Portfolio Management for Baxter’s BioScience organization says that in the biotech industry, “It’s not good enough to execute well just in R&D, or just in development. In biologics, the operations/manufacturing and development tasks are of similar complexity. Therefore, a coordinated approach across these functions is essential to ensure that you are ready to deliver what has been developed.”

Talking from his experience, Shires, who will be speaking at the marcus evans 6th Annual Pharma Resource Planning and Portfolio Management Conference, said: “We work to ensure that the project management activities span across the organization, not just R&D. It is not enough to simply have all the development pieces connected and integrated. They have to connect to manufacturing, the quality organization, the supply chain structure and the commercial launch teams, to make sure we execute the delivery of the therapy and launch it as effectively as possible.”

“This is upping the level of complexity for project and resource management and the organization, as some of these elements have considerable lead times and represent considerable investment. You have to make those decisions in time to deliver on your expected pipeline. This is a connection to portfolio management, as it is a matter of probabilities, estimates of success and resource allocations, where you are making decisions on a portfolio that in our business is never certain,” Shires said.

Your portfolio management is only as good as the project management work that it is based on. Likewise, functional expertise is an essential foundation for project management, according to Shires. “They all depend on each other and work together to guide the organization’s planning and execution. The key is to reach into those areas of expertise, that functional excellence, and connect the dots in an integrated way, in order to make the best decisions possible. This is where the art of project management comes into play. We cannot replace functional expertise; we fully rely upon it. Our job is to connect the threads that need to be in place, to execute and deliver the pipeline,” he concluded.

The Marcus Evans 6th Annual Pharma Resource Planning and Portfolio Management will take place in Philadelphia, Pennsylvania, February 26-28, 2013.

For more information, contact Michele Westergaard, Senior Marketing Manager, 312-540-3000 ext. 6625 or Michelew@marcusevansch.com.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->